New Prescriptions. Fair Pay. No Clawbacks.
A New Revenue Channel Built for Independent Pharmacy
ApalyRx partners with independent community pharmacies to fulfill prescriptions that are independently routed to the lowest net cost. As PBMs, employers, health plans, and manufacturers deploy programs through ApalyRx, a growing stream of prescriptions flows to independent pharmacy partners - with transparent reimbursement, fair dispensing fees, and no retroactive adjustments. Your pharmacy earns volume because your pricing and service earned it - not because of channel ownership or steering.
Become a Pharmacy PartnerIndependent Pharmacy Is Under Structural Pressure
The economics that sustained community pharmacy for decades are changing - and independent pharmacies are bearing the greatest burden.
Reimbursement Below Acquisition Cost
Independent pharmacies are increasingly reimbursed less than what they paid their wholesaler for the same medication. When MAC pricing adjusts without notice and reimbursement rates lag behind acquisition costs, every fill can become a loss. One industry study found that roughly 75% of claims examined were insufficient to cover pharmacy labor and drug costs. The result: dispensing the very prescriptions your patients need can threaten your business.
Retroactive Adjustments and Clawbacks
After dispensing a prescription and believing the economics are workable, pharmacies face retroactive reductions - DIR fees, post-sale adjustments, and clawbacks that erode margins months after the fact. These make it nearly impossible to predict revenue, manage cash flow, or plan for growth. The uncertainty is as damaging as the dollar amount.
Network Exclusion and Narrowing
Preferred pharmacy networks increasingly favor affiliated or chain pharmacies, reducing independent pharmacies’ access to covered lives. Nearly 30% of all U.S. retail pharmacies closed between 2010 and 2021, with independent pharmacies significantly more likely to close than chain locations. When a community pharmacy closes, patients in that area often lose their most accessible healthcare provider.
Cut Out of Emerging Supply Chains
Manufacturer-direct programs like LillyDirect and NovoCare route prescriptions through one or two nationally contracted mail-order pharmacies - cutting local independents out of the supply chain entirely. As direct-to-consumer pharmacy grows and platforms like TrumpRx accelerate the trend, independent pharmacies risk being bypassed by the very models reshaping how high-cost medications reach patients.
Independent pharmacies are closing at a rate of roughly one per day. The economics have to change - and the supply chain has to include you.
What ApalyRx Means for Your Pharmacy
A platform built to route prescriptions to independent pharmacies - not away from them
New Prescription Volume
From a Growing Platform
As PBMs, employers, health plans, and manufacturers deploy programs through ApalyRx, prescriptions flow to independent pharmacy partners. You receive volume because your pricing and service earned it. The platform currently serves 500K+ covered lives with growth to 1M+ by Q2 and 5M+ in the pipeline - every new client means more prescriptions routed to independent pharmacies.
Fair, Transparent Reimbursement
No Hidden Spreads or Clawbacks
ApalyRx operates on a pass-through model. Reimbursement is based on actual acquisition cost plus a fair dispensing fee - agreed upon upfront, not adjusted retroactively. No hidden spreads. No DIR fees. No clawbacks. No post-sale adjustments. You know exactly what you will be paid before you fill the prescription.
No Competing Interests
Structurally Independent
ApalyRx has no ownership in any dispensing channel. There is no affiliated mail pharmacy, no owned specialty pharmacy, no retail chain competing for the same prescriptions. When ApalyRx routes a prescription to your pharmacy, it is because you were the best option - not because someone upstream has a financial interest in sending it elsewhere.
Inside the New Supply Chain
Don’t Get Left Behind
While manufacturer-direct models typically contract with one or two national mail-order pharmacies, ApalyRx brings those programs to local independent pharmacies. You can serve as the dispensing pharmacy filling prescriptions directly, or as the pharmacy of record in manufacturer-direct models - conducting drug utilization review while product ships from manufacturer logistics. Either way, you are inside the supply chain, not watching it from the outside.
Your pharmacy. Your patients. Fair economics. No competing channel interests.
Dispense Directly or Serve as Pharmacy of Record
ApalyRx pharmacy partners can serve in two capacities depending on the program and product
Dispensing Pharmacy
Standard Routing Model
In standard routing programs, ApalyRx evaluates every in-scope prescription across all available channels in real time and routes to the lowest net cost. When your pharmacy offers the best option, the prescription comes to you. You dispense the medication, counsel the patient, and provide the clinical care you are trained to deliver.
- Fill prescriptions routed based on lowest net cost
- Reimbursement at acquisition cost plus fair dispensing fee
- No retroactive adjustments or clawbacks
- Volume grows as more clients deploy ApalyRx programs
Pharmacy of Record
Manufacturer-Direct Model
In manufacturer-direct programs, you serve as the pharmacy of record - the licensed pharmacist in the workflow. You conduct drug utilization review, verify the prescription, and provide clinical oversight. The physical product ships directly to the member from the manufacturer's designated logistics provider or a third-party carrier. You earn a pharmacy of record fee for your clinical role.
- Conduct DUR and final dispense verification
- Product ships from manufacturer logistics to patient
- Earn pharmacy of record fee for clinical services
- Participate in the manufacturer-direct supply chain that other models exclude you from
Both roles are critical to maintaining the structural independence that the ApalyRx model requires. Independent pharmacies - with no upstream ownership by PBMs, insurers, or GPOs - are what make the model work.
Why This Is Different
Merit-Based Routing
Prescriptions route to your pharmacy because you offered the best net cost and service - not because of network tier, channel affiliation, or volume guarantees to a competing pharmacy. Every routing decision is based on actual economics.
Full Transparency
You see the reimbursement before you fill. The economics are agreed upon upfront. There is no hidden spread between what the plan pays and what you receive. ApalyRx passes through the actual cost - your dispensing fee is your dispensing fee.
No Retroactive Adjustments
No DIR fees. No post-sale clawbacks. No retroactive MAC adjustments months after dispensing. What you are paid when you fill is what you keep. Period.
No Competing Channel
ApalyRx does not own a pharmacy. Not a mail pharmacy, not a specialty pharmacy, not a retail chain. There is no affiliated dispensing channel that benefits from steering volume away from you. Your prescriptions are earned, not redirected.
Growing Volume
ApalyRx currently serves 500K+ covered lives, growing to 1M+ by Q2 with 5M+ in the pipeline. Every new PBM, employer, health plan, or manufacturer that deploys programs through ApalyRx adds prescription volume flowing to independent pharmacy partners. The more the platform grows, the more prescriptions flow to you.
Become an ApalyRx Pharmacy Partner
Independent community pharmacies can apply to become fulfillment partners now
Apply
Complete the pharmacy partner application. Requirements include independent ownership with no vertical ties to PBMs, insurers, or GPOs, and active state pharmacy licensure.
Onboard
Complete credentialing, agree to transparent pass-through reimbursement terms, and connect to ApalyRx systems for prescription intake and fulfillment coordination.
Start Receiving Prescriptions
Once onboarded, your pharmacy is live on the platform. Prescriptions begin routing to you based on your pricing, service area, and program eligibility. Volume grows as the platform grows.
Frequently Asked Questions
ApalyRx programs typically focus on high-cost, high-variability medications - approximately 30 drugs that represent 40% or more of employer and health plan pharmacy spend. These are often specialty and branded medications where net cost differences across channels are significant. As the platform grows and more clients deploy programs, the scope of medications routed to pharmacy partners expands.
Reimbursement is based on actual acquisition cost plus a fair dispensing fee, agreed upon upfront in your partner agreement. There are no hidden spreads between what the plan pays and what you receive. No DIR fees. No post-sale clawbacks. No retroactive MAC adjustments. The economics you see before you fill are the economics you keep.
In manufacturer-direct programs, you serve as the licensed pharmacy of record. You receive the prescription through e-prescribing, conduct drug utilization review, verify the prescription, and provide clinical oversight. The physical product ships directly to the member from the manufacturer’s designated logistics provider. You earn a pharmacy of record fee for your clinical role. This model keeps you in the supply chain for manufacturer-direct programs that would otherwise bypass local pharmacies entirely.
ApalyRx provides the technology integration for prescription intake, routing confirmation, and fulfillment coordination. Specific requirements will be reviewed during onboarding. The integration is designed to work with your existing pharmacy management systems without requiring major technology investments.
Yes. Many ApalyRx pharmacy partners serve in both capacities. For some programs and products, you will be the dispensing pharmacy filling prescriptions directly. For manufacturer-direct programs, you may serve as pharmacy of record. Your role depends on the specific program, product, and routing outcome.
ApalyRx requires independent ownership - no vertical ties to PBMs, insurers, or GPOs. This is a structural requirement, not an arbitrary preference. The independence of the dispensing pharmacy is one of the five requirements of Drug Benefit Integrity. If your pharmacy has no upstream ownership by entities that also make routing decisions, you qualify.
ApalyRx is not a replacement for your existing PBM contracts. It is an additional volume channel. You continue participating in whatever PBM networks you currently contract with. ApalyRx adds a new source of prescriptions with different economics - transparent pass-through reimbursement, fair dispensing fees, no DIR fees, and no retroactive adjustments. Think of it as supplemental volume with better terms.
Volume depends on your geography, pricing, and the number of ApalyRx programs active in your service area. ApalyRx currently serves 500K+ covered lives with growth to 1M+ by Q2 and 5M+ in the pipeline. As more employers, health plans, PBMs, and manufacturers deploy programs, prescription volume flowing to independent pharmacy partners increases. Early participants are positioned for the greatest volume growth.
This is one of the most important reasons to become an ApalyRx pharmacy partner. Manufacturer-direct programs like LillyDirect and NovoCare typically contract with one or two nationally licensed mail-order pharmacies, cutting local independents out entirely. ApalyRx’s model is different - we bring manufacturer-direct programs to local independent pharmacies through the pharmacy of record structure. You provide the clinical oversight; the product ships from manufacturer logistics. Without this model, those prescriptions go to a mail-order pharmacy that has no relationship with the patient or the community.
Drug Benefit Integrity (DBI) is an independent industry standard with five structural requirements - one of which is that prescriptions are fulfilled through independent pharmacies with no vertical ownership. This means the DBI model structurally requires independent pharmacies to function. As more employers, consultants, and health plans adopt the DBI standard, the demand for independent pharmacy fulfillment grows. Your participation as an ApalyRx pharmacy partner is not just a business decision - it is part of a structural shift that positions independent pharmacy at the center of how high-cost medications should be routed and verified. Learn more at drugbenefitintegrity.com.
Your Pharmacy Belongs on This Platform
Fair Reimbursement. Growing Volume. No Competing Interests.
Independent community pharmacies are the backbone of the ApalyRx model. As more PBMs, employers, health plans, and manufacturers deploy programs through our platform, the prescription volume flowing to independent pharmacy partners grows. Apply to partner and start receiving prescriptions - with economics that work for your business.
Apply to Join the Network